Broderick Brian C increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 10.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 13,434 shares of the healthcare conglomerate’s stock after acquiring an additional 1,225 shares during the quarter. UnitedHealth Group comprises approximately 1.6% of Broderick Brian C’s investment portfolio, making the stock its 26th largest holding. Broderick Brian C’s holdings in UnitedHealth Group were worth $6,746,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Outfitter Financial LLC acquired a new position in UnitedHealth Group during the fourth quarter worth approximately $25,000. Blue Bell Private Wealth Management LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $29,000. Stuart Chaussee & Associates Inc. increased its holdings in shares of UnitedHealth Group by 55.6% in the fourth quarter. Stuart Chaussee & Associates Inc. now owns 70 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 25 shares during the period. Annapolis Financial Services LLC grew its holdings in UnitedHealth Group by 57.9% during the third quarter. Annapolis Financial Services LLC now owns 90 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 33 shares during the period. Finally, Level Financial Advisors Inc. acquired a new position in UnitedHealth Group during the fourth quarter worth $45,000. 86.07% of the stock is currently owned by institutional investors.
UNH has been the topic of several recent research reports. Raymond James upped their price objective on UnitedHealth Group from $540.00 to $620.00 and gave the company a “strong-buy” rating in a research report on Tuesday, April 19th. Morgan Stanley upped their target price on UnitedHealth Group from $570.00 to $577.00 and gave the company an “overweight” rating in a research note on Monday, April 18th. Credit Suisse Group upped their price target on UnitedHealth Group from $564.00 to $595.00 and gave the stock an “outperform” rating in a research note on Monday, April 18th. Deutsche Bank Aktiengesellschaft upped their price target on UnitedHealth Group from $482.00 to $549.00 and gave the stock a “buy” rating in a research note on Monday, April 18th. Finally, StockNews.com started coverage on UnitedHealth Group in a research note on Thursday, March 31st. They set a “strong-buy” rating for the company. Two analysts have rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $550.17.
UnitedHealth Group (NYSE:UNH – Get Rating) last posted its earnings results on Thursday, April 14th. The healthcare conglomerate reported $5.49 EPS for the quarter, beating the consensus estimate of $5.38 by $0.11. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. The firm had revenue of $80.15 billion for the quarter, compared to analysts’ expectations of $78.77 billion. During the same period last year, the firm earned $5.31 EPS. The firm’s revenue was up 14.2% compared to the same quarter last year. Equities analysts forecast that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 22nd. Investors of record on Monday, March 14th were given a $1.45 dividend. This represents a $5.80 annualized dividend and a yield of 1.11%. The ex-dividend date of this dividend was Friday, March 11th. UnitedHealth Group’s dividend payout ratio is currently 31.75%.
In other news, Director Richard T. Burke sold 3,000 shares of UnitedHealth Group stock in a transaction on Thursday, March 24th. The stock was sold at an average price of $508.80, for a total transaction of $1,526,400.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Paul R. Garcia purchased 2,146 shares of the stock in a transaction dated Tuesday, February 22nd. The shares were purchased at an average price of $464.97 per share, for a total transaction of $997,825.62. The disclosure for this purchase can be found here. Over the last 90 days, insiders sold 18,000 shares of company stock worth $8,776,840. 0.55% of the stock is owned by insiders.
UnitedHealth Group Profile (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- There’s An Institutional Floor In Keurig Dr. Pepper
- Ford Falls Despite Optimistic Outlook
- Harley-Davidson Skids Into A Buying Opportunity
- Facebook (NASDAQ: FB) Soars And Wall Street Delights
- Automatic Data Processing Is Ready To Scale New Heights
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.